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abstract
 
The Na
 
 
 
 channel is the primary target of anticonvulsants carbamazepine, phenytoin, and lamotrigine.
These drugs modify Na
 
 
 
 channel gating as they have much higher binding afﬁnity to the inactivated state than to
the resting state of the channel. It has been proposed that these drugs bind to the Na
 
 
 
 channel pore with a common
diphenyl structural motif. Diclofenac is a widely prescribed anti-inﬂammatory agent that has a similar diphenyl
motif in its structure. In this study, we found that diclofenac modiﬁes Na
 
 
 
 channel gating in a way similar to
the foregoing anticonvulsants. The dissociation constants of diclofenac binding to the resting, activated, and
inactivated Na
 
 
 
 channels are 
 
 
 
880 
 
 
 
M, 
 
 
 
88 
 
 
 
M, and 
 
 
 
7 
 
 
 
M, respectively. The changing afﬁnity well depicts the
gradual shaping of a use-dependent receptor along the gating process. Most interestingly, diclofenac does not
show the pore-blocking effect of carbamazepine on the Na
 
 
 
 channel when the external solution contains 150 mM
Na
 
 
 
, but is turned into an effective Na
 
 
 
 channel pore blocker if the extracellular solution contains no Na
 
 
 
. In
contrast, internal Na
 
 
 
 has only negligible effect on the functional consequences of diclofenac binding. Diclofenac
thus acts as an “opportunistic” pore blocker modulated by external but not internal Na
 
 
 
, indicating that the
diclofenac binding site is located at the junction of a widened part and an acutely narrowed part of the ion
conduction pathway, and faces the extracellular rather than the intracellular solution. The diclofenac binding site
thus is most likely located at the external pore mouth, and undergoes delicate conformational changes modulated
by external Na
 
 
 
 along the gating process of the Na
 
 
 
 channel.
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INTRODUCTION
 
Voltage-gated Na
 
 
 
 channels are rapidly activated and
then inactivated upon membrane depolarization, pro-
ducing transient inward Na
 
 
 
 currents that initiate action
potentials in most physiological conditions. Na
 
 
 
 channels
constitute the primary target of many local anesthetic
and anticonvulsant drugs, which typically have much
higher binding afﬁnity to the inactivated channel than
to the resting channel and therefore show a use (or
holding voltage)-dependent inhibitory effect on the
Na
 
 
 
 currents (Bean et al., 1983; Matsuki et al., 1984;
Butterworth and Strichartz, 1990; Kuo and Bean, 1994;
Xie et al., 1995; Kuo and Lu, 1997; Kuo et al., 1997).
Recently we showed that the binding rates of these use-
dependent inhibitors to the open Na
 
 
 
 channel are even
faster than those to the inactivated channel, and thus
the favorable drug binding conformation of the recep-
tor is probably made during channel activation (Yang
and Kuo, 2002). However, a complete quantitative char-
acterization of the changing afﬁnity toward different
gating states (at least the resting, activated, and inacti-
vated states) of the Na
 
 
 
 channel has never been reported
for any of the use-dependent inhibitors of this kind. A
picturesque biophysical demonstration of the shaping
of a use-dependent receptor (from an unfavorable into
a favorable drug binding site) along the basic gating
process of the Na
 
 
 
 channel thus is still lacking.
We have proposed that anticonvulsants phenytoin,
carbamazepine, and lamotrigine probably bind to
the same receptor area located in the ion conduction
pathway of Na
 
 
 
 channels with a common diphenyl
structural motif (Kuo et al., 2000; Yang and Kuo, 2002).
The exact location of the binding site(s) for the use-
dependent inhibitors is of great pharmacological and
physiological interests, because it may shed light on the
molecular mechanism underlying not only the actions of
many clinically important drugs but also some essential
gating conformational changes of the Na
 
 
 
 channel.
However, there have been different ideas on whether
the use-dependent drug binding site(s) face the extra-
cellular or intracellular side in the pore. It was proposed
that the local anesthetics and anticonvulsants bind to
the cytoplasmic side of the Na
 
 
 
 channel, chieﬂy based
on two lines of experimental ﬁndings. First, point mu-
tation of a few presumably intracellular residues in the
sixth transmembrane segment of domain IV (IVS6)
reduced the afﬁnity of local anesthetic and anticonvul-
sant drugs to the inactivated Na
 
 
 
 channels (Ragsdale et
al., 1994, 1996). Second, the permanently charged
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quaternary analogs of local anesthetic drugs could
block neuronal Na
 
 
 
 channels only when applied to the
intracellular side but not to the extracellular side (Fra-
zier et al., 1970; Strichartz, 1973; Hille, 1977). However,
because IVS6 is an important gating component in-
volved in both Na
 
 
 
 channel activation and inactivation
(McPhee et al., 1995; Doyle et al., 1998; Jiang et al.,
2002), mutations in IVS6 might well alter the activated
and inactivated Na
 
 
 
 channel conformations and thus
allosterically reduce drug afﬁnity. This could also be
one of the reasons why a point mutation in IVS6
(F1762A) was shown to affect the binding of both inter-
nal and external quaternary ammoniums (Qu et al.,
1995). It might also be noted that the blocking effect of
internal and external quaternary ammoniums was Na
 
 
 
channel isoform speciﬁc. In contrast to the foregoing
ﬁndings in neuronal Na
 
 
 
 channels, membrane-imper-
meant quaternary ammoniums signiﬁcantly blocked
the native and cloned cardiac Na
 
 
 
 channels when ap-
plied to either side of the cell membrane, and the ef-
fect of external quaternary ammoniums was signiﬁ-
cantly altered by the other extracellular pore blockers
such as tetrodotoxin or mutations of some isoform-spe-
ciﬁc residues located on the external side of the chan-
nel (Alpert et al., 1989; Qu et al., 1995; Sunami et al.,
2000; Lee et al., 2001). Moreover, it has been shown
that anticonvulsants phenytoin, carbamazepine, and la-
motrigine are effective neuronal Na
 
 
 
 channel inhibi-
tors when applied externally but not applied internally
(with continuous perfusion of the external solution in
an internally dialyzed cell; Kuo, 1998). The exact loca-
tion of the binding site(s) for the use-dependent block-
ing agents thus remains unsettled and needs to be char-
acterized in more detail.
Diclofenac is a widely prescribed anti-inﬂammatory
cyclooxygenase inhibitor rather than an anticonvul-
sant, but it also contains a diphenyl structural motif
similar to that in carbamazepine, phenytoin, and lam-
otrigine. Detailed analysis of the three–dimensional
structure of these drugs with molecular modeling fur-
ther indicates that the spatial orientation of the diphe-
nyl motif in carbamazepine is even more similar to that
in diclofenac than to that in phenytoin or lamotrigine
(Fig. 1 A; Table I; Kuo et al., 2000). In this study, we
show that diclofenac also inhibits Na
 
 
 
 currents in a
holding potential–dependent (“use-dependent”) fash-
ion like that of carbamazepine. We characterize the af-
ﬁnity between diclofenac and the Na
 
 
 
 channel not only
for the resting and inactivated states but also for the ac-
tivated (open) state of the channel, demonstrating the
gradual shaping of a use-dependent receptor along the
gating process. Most interestingly, diclofenac cannot
mimic the pore-blocking action of carbamazepine in
the presence of 150 mM external Na
 
 
 
, but is dramati-
cally turned into an effective pore blocker of the Na
 
 
 
channel when there is no external Na
 
 
 
. These ﬁndings
suggest that diclofenac binds to a receptor whose con-
formation is ﬁnely tuned not only by channel gating
Figure 1. Chemical formulae of the
drugs and inhibition of neuronal Na 
currents by diclofenac. (A) Chemical
formulae of carbamazepine and di-
clofenac. Both drugs contain the diphe-
nyl structural motif (see Table I for
more detailed comparison of the struc-
tural features). (B) Na  currents in
control, 10  M, or 30  M diclofenac
were recorded in a neuron. The cell was
held at  120 mV and then stepped to
0 mV to elicit Na  currents. 10–30  M
diclofenac produces only equivocal
inhibition of the Na  current. The
dotted line indicates the zero current
level. (C) The same experiment was
repeated in the same cell as in B except
that the holding potential was changed
to   70 mV. The control current is
much smaller than that in B but is
scaled to the same size for a better
comparison (note the difference in the
vertical scale bars). In contrast to the
ﬁndings in part B, 10–30  M diclofenac
has a pronounced and dose-dependent
inhibitory effect on the Na  current.
The dotted line indicates the zero
current level. 
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but also by external Na
 
 
 
, and whose location is most
likely at the junction of the widened external vestibule
and the narrow part of the ion conduction pathway.
 
MATERIALS AND METHODS
 
Cell Preparation
 
CA1 region was dissected from coronal slices of the whole brain
of 7- to 14-d-old Long-Evans rats and cut into small chunks. Tis-
sue chunks were treated with 0.5 mg/ml type XI trypsin (Sigma-
Aldrich) at 37
 
 
 
C for 5–10 min in dissociation medium (in mM,
82 Na
 
2
 
SO
 
4
 
, 30 K
 
2
 
SO
 
4
 
, 3 MgCl
 
2
 
, 5 HEPES, 0.001% phenol red in-
dicator, and trypsin, pH 7.4,). Each time when cells were needed,
two to three chunks were picked and triturated to release single
neurons.
 
Whole-cell Recording
 
The dissociated neurons were put in a recording chamber con-
taining Tyrode’s solution (in mM, 150 NaCl, 4 KCl, 2 MgCl
 
2
 
, 2
CaCl
 
2
 
, and 10 HEPES, pH 7.4). Whole-cell voltage clamp record-
ings were obtained using ﬁre-polished pipettes pulled from boro-
silicate micropipettes (OD 1.55–1.60 mm; Hilgenberg Inc.) and
ﬁre polished. The input resistance was 1–2 M
 
 
 
 when ﬁlled with
the standard “150 mM Cs
 
 
 
” (or “0 mM Na
 
 
 
”) internal solution
containing (in mM) 75 CsCl, 75 CsF, 2.5 MgCl
 
2
 
, 5 HEPES, 2.5
EGTA, pH adjusted to 7.4. Some of the experiments were per-
formed with the 150 mM Na
 
 
 
 (or “0 mM Cs
 
 
 
”) internal solutions
containing the same component as the 150 mM Cs
 
 
 
 internal so-
lution except that the 75 mM CsCl and 75 mM CsF were replaced
by 75 mM NaCl and 75 mM NaF. Seal was formed and the whole-
cell conﬁguration obtained in Tyrode’s solution. The cell was
then lifted from the bottom of the chamber and moved in front
of an array of ﬂow pipes (Microcapillary from Hilgenberg Inc.;
content 1 
 
 
 
l, length 64 mm) emitting either control or drug-con-
taining external recording solutions. The standard external solu-
tion was Tyrode’s solution, but in some experiments 150 mM Cs
 
 
 
(or 0 mM Na
 
 
 
) external solution containing the same constitu-
ents of Tyrode’s solution except that 150 mM NaCl was replaced
by 150 mM CsCl was used. Carbamazepine and diclofenac
(Sigma-Aldrich) were dissolved in dimethylsulfoxide to make 100
mM stock solutions, which were then diluted into Tyrode’s solu-
tion to attain the ﬁnal concentrations desired. Currents were re-
corded at room temperature (
 
 
 
25
 
 
 
C) with an Axoclamp 200A
ampliﬁer, ﬁltered at 5 kHz with four-pole Bessel ﬁlter, digitized
at 50–200 
 
 
 
s intervals, and stored using a Digidata-1200 ana-
logue/digital interface as well as the pCLAMP software (Axon
Instruments).
 
Molecular Biology
 
The plasmid pNa200 containing the rat brain type IIA (rBIIA)
Na
 
 
 
 channel 
 
 
 
-subunit cDNA is a gift from A.L. Goldin (Univer-
sity of California, Irvine, CA). F1489Q point mutation (West
et al., 1992) was done with pNa200 template and PCR-based
method (QuikChange Mutagenesis kit; Stratagene). F1489Q/
F1651A double mutation was made by the same method with
the constructed F1489Q mutation-containing pNa200 as the
template. DNA sequencing was performed, and two indepen-
dent clones were tested to exclude effects of inadvertent muta-
tions. The full-length cRNA transcript was synthesized from the
pNa200 containing F1489Q or F1489Q/F1651A mutations using
the T7 mMESSAGE mMACHINE transcription kit (Ambion).
Defolliculated 
 
Xenopus
 
 oocytes (stage V–VI) were then injected
with the cRNA transcript and maintained at 18
 
 
 
C for 1–7 d be-
fore electrophysiological studies.
 
Intracellular Recording
 
Macroscopic Na
 
 
 
 currents were examined by two-microelectrode
voltage-clamp recordings in oocytes. During recording, the oo-
cyte was continuously perfused with ND-96 solution (in mM, 96
NaCl, 2 KCl, 1 MgCl
 
2
 
, 1.8 CaCl
 
2
 
, 5 HEPES, pH 7.6) or ND-22 so-
lution (in mM, 22 NaCl, 74 CsCl, 2 KCl, 1 MgCl
 
2
 
, 1.8 CaCl
 
2
 
, 5
HEPES, pH 7.6) that did or did not contain the drugs. Both volt-
age-sensing and current-passing electrodes were ﬁlled with 3 M
KCl and had a resistance of 0.1–0.8 M
 
 
 
. Membrane potential was
controlled by a two-electrode voltage-clamp ampliﬁer with a vir-
 
TABLE I
 
Configuration of the Two Benzene Rings in Diclofenac and Three Anticonvulsant Drugs
 
a
 
Stem bond angle
 
b
 
Distance
 
c
 
Distance Distance Torsion angle
 
d
 
Degree Å, center–center Å, C1–C1 Å, C4–C4 Degree
 
Diclofenac 123.3 5.00 2.54 7.46
 
 
 
55.5, 
 
 
 
29.2
 
e
 
Carbamazepine 118.5 4.93 2.35 7.47
 
 
 
63.1, 62.4
Phenytoin 111.0 4.84 2.52 7.12
 
 
 
57.4, 
 
 
 
56.5
Lamotrigine NA 4.38 1.50 7.10
 
 
 
59.9, 122.1
 
a
 
Models of the tertiary drug structure were built by the Macromodel version 4.5 program (Department of Chemistry, Columbia University, 1994). More
than 200 conformations were picked, and energy minimization using the Monte Carlo method and MM2 force-ﬁeld parameters was then exercised. Most
of the data have been published before in a more comprehensive chart (Kuo et al., 2000).
 
b
 
In each drug molecule, the carbon or nitrogen atom that the two benzene rings directly connect to is designated as the pivotal atom. The C–C or N–C
bond connecting the pivotal atom and the benzene ring is designated as the stem bond. The angle made by the two stem bonds at the pivotal atom is the
stem bond angle. In lamotrigine, the two benzene rings are connected to each other directly, and thus no stem bond or stem bond angle could be deﬁned.
 
c
 
The distance between the two benzene rings are measured between the centers (center–center), the two C1 atoms (C1–C1), or the two C4 atoms (C4–C4)
of the rings. C1 is the carbon atom forming the stem bond with the pivotal atom, or in lamotrigine, it is the atom directly connected to the other benzene
ring. C4 is the atom farthest to C1 in the ring.
 
d
 
The torsion angle deﬁnes rotation of the benzene ring. The stem bond is the rotating axis, and the plane formed by the two stem bonds is the reference
plane. For lamotrigine, there is a hypothetical reference plane that contains both rings by neglecting ring rotation ﬁrst. Each ring then rotates with the
bond connecting the two rings being the rotating axis. Positive angle means clockwise rotation if one views the ring from the pivotal atom.
 
e
 
The benzene rings in diclofenac have more ﬂexible torsion angles than the other drugs. There are more than ﬁve similarly low-energy conformers with
torsion angles distributed between 
 
 
 
55.5, 
 
 
 
29.2 and 43.2, 53.2 degrees. 
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tual ground circuit (model OC-725C; Warner Instrument). Cur-
rents were recorded at room temperature (
 
 
 
25
 
 
 
C), ﬁltered at 5
kHz, digitized at 20–100 
 
 
 
s interval, and stored using a Digi-
data-1200 analogue/digital interface as well as the pCLAMP soft-
ware (Axon Instruments). All statistics in this study are given as
mean 
 
 
 
 SEM.
 
RESULTS
 
Different Inhibitory Effect of Diclofenac on Neuronal Na
 
 
 
 
Currents Elicited from Different Holding Potentials
 
Fig. 1 B shows that 10–30 
 
 
 
M diclofenac produces neg-
ligible inhibition of the macroscopic neuronal Na
 
 
 
 cur-
rents elicited from a holding potential of 
 
 
 
120 mV.
However, the same concentrations of diclofenac signiﬁ-
cantly inhibits the currents elicited from a more depo-
larized holding potential of 
 
 
 
70 mV, demonstrating a
voltage (holding potential)-dependent inhibitory effect
of diclofenac on Na
 
 
 
 channels.
 
Measurement of the Binding Afﬁnity of Diclofenac to the 
Inactivated Neuronal Na
 
 
 
 Channel
 
We characterize the voltage-dependent effect of di-
clofenac in more detail by examination of the inacti-
vation curve, which describes the voltage-dependent
steady-state distribution of the Na  channel between
the resting (R) and the inactivated (I) states (Scheme
1; Fig. 2).
We have seen in Fig. 1 B that diclofenac evidently in-
hibits Na  currents elicited from a holding potential of
 70 mV, where many channels would occupy the inac-
tivated state, but not the currents elicited from  120
mV, where most channels shall stay in the resting state.
Diclofenac thus probably binds much more tightly to
the inactivated channel than to the resting channel. In
other words, binding of diclofenac would favor redistri-
bution of the channel to the inactivated state and con-
sequently decrease the Na  currents. Let KI and KR be
the dissociation constants of diclofenac binding to the
(SCHEME 1)
by the difference between the Vh values in control and in different
concentrations of diclofenac. The mean  V values (in mV) are
3.7   2.1 (n   3), 5.8   1.7 (n   5), 12.1   1.2 (n   6), and
19.3   0.9 (n   12) for 10, 30, 100, and 300  M diclofenac, re-
spectively. (C) The mean  V values in B and a k value of 5.4 are
used to calculate exp( V/k), which is plotted against diclofenac
concentrations to determine the dissociation constant of di-
clofenac binding to the inactivated channel. The solid line is
the ﬁt of the form (see Eq. 1 in the text): exp( V/k)   [1  
(D/6.8)]/[1   (D/880)], where a KR value of 880  M is taken
from Fig. 7 D, and D is the diclofenac concentration in  M.
Figure 2. Shift of the inactivation curve of neuronal Na 
channels by diclofenac. (A) The inactivation curves are docu-
mented in the absence or presence of different concentrations of
diclofenac. The neuron was held at  120 mV and stepped to the
indicated inactivating prepulses for 9 s. The neuronal Na  currents
were then measured at 0 mV right after the 9-s prepulses. The
available fraction is deﬁned as the normalized current relative to
the current elicited after a prepulse of  120 mV. The solid lines
are the ﬁts to each set of data with a Boltzmann function 1/(1  
exp((V    Vh)/k)), where the Vh values (in mV) are  73.7,
 74.6,  81.4,  87.5, and  95.2 in 0 (control), 10, 30, 100, and
300  M diclofenac, respectively. Because the slope of the ﬁtting
curves in different diclofenac concentrations always stay close to
the slope in control, the above Vh values are obtained from the ﬁts
with a ﬁxed k value of 5.4 (the mean of the k values in control).
(B) The mean value of the shift of the inactivation curve by dif-
ferent concentrations of diclofenac. The shift ( V) is determined469 Yang and Kuo
inactivated and resting channels, respectively, and D
be the concentration of diclofenac. Based on the sim-
pliﬁed gating Scheme 1, diclofenac should keep the
shape (the slope factor k) of the inactivation curve un-
changed but shift the inactivation curve leftwardly on
the voltage axis, with the extent of the shift ( V) deter-
mined by KI,  KR, and D according to the following
equation (Bean et al., 1983; Bean, 1984):
(1)
Fig. 2 (A and B) shows that diclofenac indeed dose
dependently shifts the inactivation curve without signif-
icant alteration of the shape of the curve. The exp( V/k)
values in different concentrations of diclofenac are ﬁt-
ted with Eq. 1 and a KR value of 880  M (see Fig. 7 D).
The dissociation constant between diclofenac and the
inactivated Na  channel (KI) obtained from the ﬁt is
 7  M (Fig. 2 C), a value smaller than the KI of car-
bamazepine in the same preparation (i.e.,  25   M;
Kuo et al., 1997). Because the KR value is probably
 880  M (see Fig. 7 D), diclofenac binding to the inac-
tivated Na  channel should be at least 100 times more
tightly than to the resting Na  channel.
Mutual Exclusion of Diclofenac and Carbamazepine Binding 
to the Inactivated Na  Channel
Diclofenac and carbamazepine share a diphenyl struc-
tural motif and both stabilize Na  channel inactivation
with much higher binding afﬁnity to the inactivated
channel than to the resting channel (Figs. 1 and 2).
We therefore investigate the interaction between di-
clofenac and carbamazepine binding to the inactivated
Na  channel by examination of the shift of the inactiva-
tion curve in the simultaneous presence of both drugs
(Fig. 3, see also Kuo, 1998). We have described that
exp( V/k) is equal to [1 (D/KI)]/[1 (D/KR)] (Eq.
1) in the presence of one drug. Because of the rela-
tively large value of KR for either diclofenac or carba-
mazepine, D/KR could be neglected in equation 1 for
simplicity. The equation then becomes
(2)
In the presence of two different drugs, the channel
may or may not be doubly occupied by the two different
drug molecules. If both drugs bind to the same receptor
in the inactivated channel, or if binding of one drug al-
losterically antagonizes binding of the other, then the
channel cannot be doubly occupied (see the one-site
model in Fig. 3 A; Kuo, 1998). Based on the one-site
model and Eq. 2, the shift ( V) of the inactivation curve
in the mixture of two drugs would be given by
(3)
exp ∆Vk ⁄ () 1D K I ⁄ () + [] 1D K R ⁄ () + [] ⁄ . =
exp ∆Vk ⁄ () 1D K I ⁄ () + . ≅
exp ∆Vk ⁄ () 1D 1 K I,1 ⁄ () D2 KI,2 ⁄ () , ++ ≅
where D1 and D2 are the concentrations of the two
drugs, and KI,1 and KI,2 are the KI values of the two
drugs, respectively. On the other hand, if the two drugs
have separate and unrelated binding sites, then they
may doubly occupy the channel (see the two-site model
in Fig. 3 A; Kuo, 1998). In this case, there would be an
extra state (i.e., ID1D2) signaling simultaneously dou-
ble occupancy of the channel by the two drugs. The
shift ( V) in the mixture of two drugs then would be
given by
(4)
It is evident that the one-site model and the two-site
model predict very different shifts of the inactivation
curve in a mixture of two drugs, especially in high drug
concentrations. With a KI value of  7  M for diclofenac
(Fig. 2), a KI value of  25  M for carbamazepine (Kuo
et al., 1997), and a slope factor k of 5.4, the predicted
shift ( V) by Eq. 2 in the presence of a single drug
would be 20.4 mV and 13.9 mV for 300  M diclofenac
and 300  M carbamazepine, respectively. Both values
are very close to the experimental data (19.3 and 13.9
mV for diclofenac and carbamazepine, respectively; Fig.
3, B and C). On the other hand, in the presence of a
mixture of 150  M diclofenac and 150  M carba-
mazepine, the predicted shift ( V) of the inactivation
curve would be highly model dependent (18.1 mV by
the one-site model and 27.3 mV by the two-site model).
The experimental data ( 16 mV; Fig. 3 C) are evidently
very much consistent with the prediction by the one-site
model rather than the two-site model. This ﬁnding
strongly argues against simultaneous (double) occu-
pancy of the inactivated Na  channel by diclofenac and
carbamazepine. Diclofenac and carbamazepine thus
cannot have completely unrelated binding sites in the
inactivated Na  channel. The two drugs must either
bind to the same receptor site or bind to two separate
sites whose conformational changes are allosterically
and strictly interconnected with each other.
Lack of Pore-blocking Effect of Diclofenac on the Open Na  
Channel in 150 mM External Na 
We have previously demonstrated that carbamazepine
and imipramine accelerate macroscopic Na  current
decay in a linear dose-dependent fashion with mac-
roscopic binding rate constants of  1.1    106 and
 1.1   107 M 1s 1, respectively (Yang and Kuo, 2002).
This ﬁnding strengthens the view that these use-depen-
dent inhibitors bind to the Na  channel with a one-to-
one binding stoichiometry, and further suggests that
carbamazepine  and imipramine block the open Na 
channel pore in addition to stabilization of a noncon-
ducting (or inactivated) state connected to the open
state. This is because if only the latter case were true,
exp ∆Vk ⁄ () 1D 1 K I,1 ⁄ () D2 KI,2 ⁄ ()
D1 KI,1 ⁄ () D2 KI,2 ⁄ () ×
+++
.
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then the forward rate (rate of genesis of this noncon-
ducting state) must be much faster than 330 to 3300 s 1
to sustain the time constant of relaxation observed in
the highest concentration ( 300   M) of carbamaz-
epine and imipramine (Yang and Kuo, 2002). Also, the
corresponding backward rate must be quite sizable as
compared with the forward rate to sustain the dose-
dependent current decrease with time constants of re-
laxation linearly related to drug concentrations. It is
thus hard to conceive such a nonconducting state, be-
cause it can be neither the fast inactivated state, which
has a very slow backward rate (i.e., very high binding af-
ﬁnity of the inactivation lid to the open channel), nor
the slow inactivated state, which usually takes a few
hundred milliseconds or seconds to develop. If di-
clofenac and carbamazepine share the same binding
site in Na  channels, it is intuitive that diclofenac
should also block the pore. Surprisingly, we found that
diclofenac cannot block the open neuronal Na  chan-
nel pore like what carbamazepine and imipramine do.
With its even higher binding afﬁnity to the inactivated
channel than carbamazepine, diclofenac in concentra-
tions of 300  M to 1 mM (43- to 143-fold of KI) does
not show any acceleration of the macroscopic current
decay as that 300  M (12-fold of KI) carbamazepine
does (Fig. 4 A; Yang and Kuo, 2002). Actually, the cur-
rent decay is slightly retarded rather than accelerated
by diclofenac (Fig. 4, B–D). The signiﬁcant and concen-
tration-dependent retardation of current decay by di-
clofenac argues against the possibility that the lack of
blocking effect is due to insigniﬁcant binding of di-
clofenac onto the open channel (e.g., the binding rate
of diclofenac is too slow or the binding afﬁnity is too
low to the open channel). Instead, it seems that di-
Figure 3. Shift of the inacti-
vation curve of neuronal Na 
channels by carbamazepine
and diclofenac. (A) Simpliﬁed
diagrams describing the pos-
sible action of the drugs on
different Na  channel gating
states. R and I denote the
resting  and the inactivated
states of the steady-state
channel, respectively. D1 and
D2 denote two different
drugs. V denotes that the
distribution between R and I
states is voltage dependent.
The one-site model is illus-
trated in the upper panel,
where D1 and D2 share the
same receptor site and thus
the inactivated channel can
only be bound with one drug
molecule at a time. For the
sake of simplicity, we did not
show a scheme illustrating
that the two different drugs
bind to two different inacti-
vated conformations allosteri-
cally incompatible with each
other. However, the basic
quantitative analysis (e.g.,
Eq. 3 in the text) would be
the same whether binding of
one drug precludes binding
of the other directly or allo-
sterically. The lower panel
represents the gating scheme of the two-site model, where the two drugs have separate and unrelated binding sites and thus could doubly
occupy the inactivated channel. (B) The experimental protocol and the ﬁtting procedures (with a ﬁxed k value of 5.4) are similar to the
case in Fig. 2 A. The Vh values of the inactivation curves are  48.5,  64.7,  69.2, and  67.3 mV for control, 300  M carbamazepine,
300  M diclofenac, and 150  M carbamazepine plus 150  M diclofenac, respectively. (C) Shift of the inactivation curve in the presence of
diclofenac and/or carbamazepine. The shift ( V) is calculated by the difference between the Vh values in control and in the presence of
different drugs. The mean values of  V (in mV) are 19.3   0.9 (n   12), 13.9   1.4 (n   4), and 15.9   1.5 (n   9) for 300  M diclofenac,
300  M carbamazepine, and 150  M carbamazepine plus 150  M diclofenac, respectively. The data of 300  M diclofenac are from the
same cells measured in Fig. 2 B. The predicted shift in the presence of both drugs by the one-site model (the striped bar) is much closer to
the experimental data (the black bar) than the prediction by the two-site model (the white bar) (see text for more details).471 Yang and Kuo
clofenac signiﬁcantly binds to the open channel and
slightly retards channel inactivation without simulta-
neously blocking the pore. One may also note that the
current peak is slightly shifted rightwardly (i.e., the
time to current peak is slightly lengthened) and is re-
duced rather than enhanced despite of possible stabili-
zation of the open channel by high concentrations of
diclofenac (Fig. 4, A and B). The slightly rightwardly
shifted and reduced peak implies that diclofenac, in
such high concentrations, may bind to the resting Na 
channel and consequently slows the activation pro-
cess upon depolarization, and/or that the diclofenac-
bound open channel could still conduct Na  currents
but with a slightly decreased conductance. In any case,
there must be signiﬁcant diclofenac binding to the Na 
channel without blocking the channel pore, so that the
gating alterations could be manifest.
Voltage-dependent Enhancement of the Inactivation-deﬁcient 
F1489Q Mutant Na  Currents by the Stabilization Effect of 
Diclofenac on the Activated Channel
To verify the effect of diclofenac on resting and open
Na  channels, we examined diclofenac action on the
inactivation-deﬁcient mutants (i.e., F1489Q mutant or
F1489Q/F1651A double mutant RIIA Na  channels ex-
pressed in oocytes). The F1489Q mutation is located at
the intracellular loop connecting domains III and IV
and presumably weakens binding of the inactivation
“lid” to the open channel (West et al., 1992). Fig. 5 A
shows that 300  M and 1 mM diclofenac only mildly in-
crease the peak of the inactivation-deﬁcient F1489Q
current elicited by a step depolarization to 0 mV from a
holding potential of  120 mV. However, if the current
is elicited by a less depolarized potential such as  20
mV, the peak current enhancement effect of diclofenac
becomes much more evident (Fig. 5 B), making the
currents as large as  1.5-fold of the original ones (Fig.
5 C). The following simpliﬁed Scheme 2 illustrates gat-
black horizontal bars indicate the external solutions (Tyrode’s
solution or Tyrode’s solution with different concentrations of
diclofenac) in which the neuron stayed. The time constant from a
monoexponential ﬁt to the macroscopic Na  current decay is
lengthened by diclofenac in a dose-dependent fashion. The
diclofenac effect can be readily “washed out” when the external
solution is switched back to the control Tyrode’s solution. (D)
Opposite effects of diclofenac and carbamazepine on the current
decay rate. The decay rate is determined by the inverse of the time
constant obtained from a monoexponential ﬁt to the decay phase
of the current. The relative decay rate is deﬁned by the ratio
between the decay rates in the presence of different drugs and
in control, and are 0.86   0.02 (n   9, drug/control), 0.78   0.01
(n   11), 1.08   0.02 (n   6), 1.23   0.03 (n   9) for 300  M
diclofenac, 1 mM diclofenac, 100  M carbamazepine, and 300  M
carbamazepine, respectively. The dashed line indicates the relative
decay rate of 1.
Figure 4. The effect of diclofenac on macroscopic neuronal Na 
currents. (A) The neuron was held at  120 mV and stepped to 0
mV to elicit Na  currents. The external solution contains 150 mM
NaCl, and the internal solution contains 150 mM CsCl (for details
of the composition of the solutions, see materials and methods).
300  M to 1 mM diclofenac mildly and dose dependently reduces
the current peak as well as increases the time to peak without
apparent acceleration of current decay. The dotted line indicates
the zero current level. (B) The currents in A are superimposed
and scaled to the same current size, showing that diclofenac shifts
current peak rightwardly as well as slows current decay in a dose-
dependent fashion. (C) The neuron was exposed to repeated
pulses, which are stepped from  120 mV to 0 mV for 12 ms with
an interpulse interval of 3 s to elicit a series of Na  currents. The472 An Opportunistic Blocker of the Na  Channel Pore
ing of the inactivation-deﬁcient mutant channel. The
inactivated state is disregarded in this scheme, where C,
O, CD, and OD refer to the closed, open, drug-bound
closed, and drug-bound open states, respectively, and V
denotes the voltage-dependent gating processes.
Based on Scheme 2, the test-pulse voltage depen-
dence of the enhancement effect of diclofenac in Fig. 5
would suggest that diclofenac enhances the currents by
increasing the relative occupancy of the open state. In
other words, the enhancement of the mutant currents
can be explained by the ideas that both O and OD in
Scheme 2 can conduct Na  ions, and that diclofenac
actually makes more distribution of channels to the
open state (i.e., there is a higher afﬁnity of diclofenac
binding to the open than to the resting states). In that
case, diclofenac binding should cause a leftward shift
(in the voltage axis) of the “activation curve” describing
distribution between the closed and the open states of
the channel. We therefore examine the enhancement
effect of diclofenac on peak F1489Q mutant currents
over a wide range of test-pulse potentials (Fig. 6). Di-
clofenac causes a concentration-dependent leftward
shift in the activation curve (the normalized conduc-
tance–voltage curve) of the F1489Q mutant channel
(Fig. 6 A). Based on similar rationales to the shift in the
inactivation curve (Eq. 1), the shift of the activation
curve by a ﬁxed concentration of diclofenac would be
predicted by the following equation, where KO and KR
denote the dissociation constants of diclofenac binding
to the open and resting channels, respectively.
(5)
We therefore have a KO of  88  M with a KR value of
880  M (Fig. 6, B and C, the KR value is taken from Fig.
7 D). These ﬁndings are well consistent with the idea
that submillimolar diclofenac can effectively bind to
the open Na  channel without signiﬁcantly blocking its
pore (i.e., OD in Scheme 2 is still a conducting state).
Even Larger Enhancement of the Inactivation-deﬁcient 
F1489Q/F1651A Double Mutant Na  Currents by Diclofenac 
in High Concentrations of External Na 
The biphasic macroscopic current decay implies that
there is still residual fast inactivation followed by a slow
inactivation process in the F1489Q mutant channel
(Lawrence et al., 1996; Nuss et al., 1996). To ensure
more complete removal of fast inactivation, we make an-
other mutant containing not only F1489Q but also
F1651A mutations. The F1651A mutation is located at
(SCHEME 2)
exp ∆Vk ⁄ () 1D K O ⁄ () + [] 1D K R ⁄ () + [] ⁄ =
Figure 5. Diclofenac enhancement of the inactivation-deﬁcient
F1489Q mutant currents. (A) The oocyte expressing the F1489Q
mutant channel was held at  120 mV and stepped to 0 mV to
elicit currents. The control Na  current recorded in ND-96 solu-
tion shows biphasic current decay (an initial fast phase followed by
a slow phase of decay). 300  M to 1 mM diclofenac only minimally
or equivocally increases the peak current. The dotted line indicates
the zero current level. (B) The same oocyte as that in A was
stepped to  20 mV instead of 0 mV to elicit Na  currents. The
activation kinetics are consequently slower, but the enhancement
effects of 300  M and 1 mM diclofenac are stronger than that in A.
(C) The F1489Q peak currents elicited by 0 (black bars) or  20 mV
(gray bars) pulses in different concentrations of diclofenac are
normalized to that in the control (no diclofenac) condition to
obtain the relative peak current. The dashed line indicates the
relative peak current of 1. The enhancement effect of diclofenac
on peak currents is dependent on both the test pulse voltage and
the diclofenac concentration.473 Yang and Kuo
the S4–S5 linker in domain IV, presumably disrupting
the “receptor” for the inactivation lid (Depp and Gol-
din, 1996; Lerche et al., 1997; McPhee et al., 1998). The
F1489Q/F1651A double mutation almost completely
abolishes fast inactivation in Na  channels. The current-
enhancing effect of diclofenac indeed is more evident
in the double mutant channel (Fig. 7, A and B), pre-
sumably due to less “contamination” by residual fast in-
activation. 300  M to 1 mM diclofenac unequivocally in-
creases the peak of the double mutant current elicited
at 0 mV and dramatically enhances the current elicited
at   20 mV. The current peak is augmented in a di-
clofenac concentration-dependent fashion (Fig. 7 C).
The test-pulse voltage dependence of the enhancement
effect of diclofenac in Fig. 7 again strongly supports the
view that diclofenac increases the relative occupancy of
the open state in Scheme 2, where the OD state remains
unblocked and can readily conduct Na . The occu-
pancy of the open state is more signiﬁcantly increased at
weaker (e.g.,  20 mV) than at stronger depolarization
(e.g., 0 mV), probably because this occupancy is already
saturating at 0 mV in the drug-free condition. On the
other hand, carbamazepine is obviously an open pore
blocker of the Na  channel because it always accelerates
the decay and reduces the peak of both native and inac-
tivation-deﬁcient mutant Na  currents in the same ex-
perimental conditions (e.g., Fig. 4 D and Fig. 7 A).
Measurement of the Binding Afﬁnity of Diclofenac to the 
Resting Na  Channel
We have seen that diclofenac selectively binds to the ac-
tivated and inactivated Na  channel (e.g., Figs. 2 and 6).
It would be desirable to estimate the binding afﬁnity of
diclofenac to the resting channel to have a more solid
idea of the binding afﬁnity changes along the whole
gating process. However, an accurate estimate of di-
clofenac binding afﬁnity to the resting Na  channel
may not be easy because the afﬁnity presumably is
very low and the resting channel itself is electrophysio-
Figure 6. Shift of the normalized conductance–voltage curve of
the F1489Q mutant channel by diclofenac. (A) The normalized
conductance–voltage curve of the F1489Q mutant channel in
different concentrations of diclofenac. The oocyte expressing
F1489Q mutant Na  channels was held at  120 mV and stepped
to different test voltages to elicit Na  currents. The maximal
conductance (Gmax) is given by the slope of the linear regression
ﬁt to the data points between  10 and  40 mV in the peak
current–voltage plot, and the reversal potential (Vrev, in mV) is
estimated by extrapolating the foregoing linear regression to the
zero current level. The normalized conductance is then deter-
mined by Ipeak/((V   Vrev)*Gmax), where Ipeak and V are the peak
current amplitude and the test voltage (in mV), respectively. The
normalized conductance is plotted against the test voltage, and
then ﬁtted with a Boltzmann function of the form: 1/(1   exp
((V   Vh)/4.8)), where the Vh values (in mV) are  13.7,  16.9,
 17.8, and  19 in 0 (control), 100, 300, and 1000  M diclofenac,
respectively. Because the slope of the ﬁtting curves in diclofenac
always stays close to the slope in control, the Vh values are obtained
from the ﬁts with a ﬁxed k value of 4.8 (the mean of the k values in
control) to facilitate the following quantitative analysis. (B) Mean
shift of the normalized conductance–voltage curve by different
concentrations of diclofenac. The shift ( V) is determined by the
difference between the Vh values in control and in different
concentrations of diclofenac. The mean  V values (in mV) are
3.8   1.1 (n   3), 5.6   1.1 (n   3), and 8.4   0.7 (n   4) for 100,
300, and 1000  M diclofenac, respectively. (C) The mean  V
values in B and a k value of 4.8 are used to calculate exp( V/k),
which is plotted against diclofenac concentrations to determine
the dissociation constant between diclofenac and the activated
channel. The solid line is the ﬁt of the form (see Eq. 5 in the
text) exp( V/k)   [1   (D/88)]/[1   (D/880)], where D is the
diclofenac concentration in  M, and a KR value of 880  M is taken
from Fig. 7 D.474 An Opportunistic Blocker of the Na  Channel Pore
logically silent (i.e., no observable ionic conductance
through the resting channel). Diclofenac is not a pore
blocker in this experimental conﬁguration. However,
binding of diclofenac evidently alters the C–O transi-
tion to augment Na  currents in the inactivation-deﬁ-
cient mutants. We therefore try to have an estimate of
the binding afﬁnity of diclofenac to the resting Na 
channel based on Scheme 2 where a step depolarization
will drive channels in states C (diclofenac-free resting
state) and CD (diclofenac-bound resting state) to states
O and OD to elicit Na  currents. As a ﬁrst approxima-
tion, we assume that the binding rate of diclofenac onto
the channel is much slower than channel gating itself.
The resting Na  channel in states C and CD would then
Figure 7. Diclofenac enhancement and carba-
mazepine inhibition of the F1489Q/F1651A double
mutant current. The experimental protocol is the
same as that in Fig. 5. (A) The inactivation phase of
the macroscopic current in the double mutant is
more completely abolished (i.e., the current decays
even slower in the double mutant) than in the
F1489Q mutant. Also, diclofenac shows more en-
hancement of the peak current evoked by a pulse at
0 mV in the double mutant than in the F1489Q
mutant (Fig. 5 A). In sharp contrast, carbamazepine
evidently reduces the double mutant current. The
dotted line indicates the zero current level. (B) Di-
clofenac has an even stronger enhancement effect
on the double mutant current evoked by a pulse at
 20 mV in the same oocyte as that in A. (C) Another
oocyte expressing the F1489Q/F1651A double
mutant channel was exposed to repeated pulses to
 20 mV for 100 ms to elicit a series of mutant Na 
currents (sweeps) with a 4-s interpulse interval at
 120 mV. The black horizontal bars indicate the
external solutions (ND-96 only or ND-96 with differ-
ent concentrations of diclofenac) in which the oocyte
stayed. The double mutant current peak is greatly en-
hanced by diclofenac in a concentration-dependent
fashion. The diclofenac effect can be readily “washed
out” when the external solution is switched back to
the control ND-96 solution. (D) Estimation of the
afﬁnity of diclofenac binding to the resting Na 
channel by analysis of the increase of the F1489Q/
F1651A double mutant current. The F1489Q/
F1651A double mutant peak current (the maximal
inward current) elicited by a  20 mV pulse in dif-
ferent concentrations of diclofenac is normalized to
that in the control (no diclofenac) condition to obtain
the relative peak current. The enhancement effect
on the currents is diclofenac concentration depen-
dent and can be well described by a one-to-one
binding curve of the form: relative peak current  
(1     2.7*D/880)/(1     D/880), where D is the
concentration of diclofenac in  M (see text for more
details).475 Yang and Kuo
approximately be “separately” activated via the C–O
route and the CD–OD route, respectively. The increase
of the mutant current peak by diclofenac thus may serve
as a rough estimate of the relative occupancy between
states C and CD. The dissociation constant (KR) be-
tween diclofenac and the resting Na  channel could
therefore be measured. Fig. 7 D plots the increase of the
double mutant current peak against the diclofenac con-
centration. The experimental data can be reasonably ﬁt-
ted with a one-to-one binding curve, giving a KR value of
 880  M. It should be noted that a KR value of  880
 M is very likely a slight underestimate because mild
“contamination” by additional binding of diclofenac to
the (partially and fully) activated channels may happen
during the rising phase of the current.
Diclofenac as a Pore Blocker of the Na  Channel in the 
Absence of External Na 
It is intriguing that diclofenac shares very similar fea-
tures of Na  channel gating modiﬁcation to carba-
mazepine (Figs. 2 and 3; Kuo et al., 1997), but the effect
on ion permeation is fundamentally different between
these two drugs (Figs. 4 and 7; Yang and Kuo, 2002). In
view of the possibility that the pore-blocking effect
may be modulated by permeating ions, we examine
the effect of Na  on the action of carbamazepine and
diclofenac. Surprisingly, we found that diclofenac is
turned into an effective pore blocker and evidently ac-
celerates the macroscopic neuronal Na  current decay
when the Na  ions in the external solution are replaced
by Cs  (0 mM external and 150 mM internal Na ; Fig.
8, A and B). The onset of the effect is very rapid (Fig. 8
C), exactly analogous to the effect of carbamazepine in
150 mM external Na  (Yang and Kuo, 2002). The linear
correlation between the acceleration of current decay
and the diclofenac concentration indicates a simple bi-
molecular reaction and gives a diclofenac binding rate
Figure 8. Diclofenac inhibition of outward neuronal Na  currents
in 0 mM external and 150 mM internal Na . (A) The cell was
held at  120 mV and stepped to 0 mV to elicit Na  currents. The
external solution contains no Na  ions but 150 mM Cs , and
the internal solution contains 150 mM Na  (for details of the
composition of the solutions, see materials and methods). 1 mM
diclofenac has a stronger inhibitory effect on the current than
300  M carbamazepine, and both drugs accelerate current decay
(see B). The dotted line indicates the zero current level. (B) The
currents in A are superimposed and scaled to the same current
size. It is evident that 300  M carbamazepine accelerates current
decay, and 1 mM diclofenac is even stronger in doing so. (C) In
0–1000   M diclofenac, the decay phase of the macroscopic
outward Na  currents in the absence of external Na  is ﬁtted with
a monoexponential function. The inverse of the time constant
in control is subtracted from the inverse of the time constant in
diclofenac to give the macroscopic drug binding rate to the open
channel. The line is a linear regression ﬁt to the macroscopic
binding rates in different concentrations of diclofenac with a slope
of 4.1   105 M 1s 1. (D) Comparison of the effects of diclofenac and
carbamazepine on the macroscopic current decay rate in different
ionic conditions. The neurons were held at  120 mV and stepped
to 0 mV to elicit Na  currents. The relative current decay rate is
determined in the same way as that described in Fig. 4 D. The
dashed line indicates the relative decay rate of 1. Diclofenac
retards current decay in the presence of 150 mM external and
0 mM internal Na  solutions but accelerates current decay in the
presence of 0 mM external and 150 mM internal Na  solutions,
both in a diclofenac concentration–dependent fashion. On the
other hand, carbamazepine always accelerates current decay
irrespective of the Na  concentration in the solutions.476 An Opportunistic Blocker of the Na  Channel Pore
constant of 4.1   105 M 1s 1 onto the open neuronal
Na  channel. This value is close to the previously re-
ported binding rate constant of carbamazepine to the
open channel (1.1   106 M 1s 1; Yang and Kuo, 2002).
Actually the binding rate constants to the inactivated
Na  channel are also similar between these two drugs,
and are  15–30 times slower than binding to the open
channel in both cases (unpublished data; Kuo et al.,
1997). In any case, it is clear that carbamazepine is al-
ways an open channel pore blocker and accelerates the
macroscopic current decay irrespective of the external
Na  concentration, but diclofenac is a more versatile or
an “opportunistic” pore blocker modulated by the Na 
ion in the external solution (Fig. 8 D). At ﬁrst glance,
the fundamentally different effects of diclofenac and
carbamazepine on ion permeation in 150 mM external
Na  may seem to suggest two different sites for these
two drugs. The mutual exclusion between binding of
the two drugs then would be more likely ascribable to
an allosteric rather than a direct interaction. However,
the ﬁnding that diclofenac is turned into a pore blocker
and shows an effect exactly analogous to carbamazepine
in the absence of external Na  would favor the possibil-
ity of a common binding site and a direct interaction be-
tween these two drugs again. In any case, the intriguing
opportunistic pore-blocking effect strongly suggests that
there is a binding site for the use-dependent Na  chan-
nel inhibitor at the junction of the widened external
vestibule and the narrowed part of the pore (see dis-
cussion and Fig. 11).
Less Enhancement Effect of Diclofenac on Inactivation-
deﬁcient Mutant Na  Currents in Lower Concentration 
of External Na 
We also examined the effect of different concentra-
tions of external Na  on the action of diclofenac in the
inactivation-deﬁcient mutant channels. We have seen
that 1 mM diclofenac markedly enhances the F1489Q
mutant current elicited by a  20-mV pulse in ND-96
external solution (containing 96 mM Na ; Fig. 5 B).
However, the same concentration of diclofenac can
only barely enhance the F1489Q mutant current when
the external Na  concentration is decreased to 22 mM
(in ND-22 solution; Fig. 9). It should be noted that the
only difference in the experimental conditions here is
the external Na  ion concentration, as the internal
Na  concentration is unchanged and the macroscopic
Na  currents are always inward (e.g., the currents in
Fig. 4 A and Fig. 8 A have opposite directions of cur-
rent ﬂow). The ﬁndings in Fig. 9 thus are not only con-
sistent with Fig. 8, but further suggest that the major
determinant of the blocking effect of diclofenac on the
open Na  channel pore is external Na  rather than the
direction of current ﬂow or the internal ionic condi-
tions (also see below).
Diclofenac as an “Opportunistic” Na  Channel Pore Blocker 
Modulated by the External rather than the Internal Na 
Fig. 10 A further examines the effect of diclofenac on
neuronal Na  currents in symmetrical 150 mM Na  so-
lutions (both internal and external solutions contain
150 mM Na ). 1 mM diclofenac slightly reduces and
rightwardly shifts the macroscopic current peak but
does not accelerate the current decay in symmetrical
Na  solutions. This is similar to the case in 150 mM ex-
ternal and 0 mM internal Na  (Fig. 4, A and B) but dis-
tinct from the case in 0 mM external and 150 mM inter-
nal Na , where the current decay is accelerated and the
current peak is reduced but not shifted by diclofenac
(Fig. 8, A and B). This ﬁnding again supports the idea
Figure 9. Comparison of diclofenac enhancement of the
F1489Q mutant current in external solutions containing high and
low concentrations of Na . (A) The oocyte expressing the F1489Q
mutant channel was held at  120 mV in the ND-96 solution
(containing 96 mM Na ) or in the ND-22 solution (containing
only 22 mM Na , see materials and methods) and stepped to
 20 mV for 100 ms to elicit the Na  currents. 1 mM diclofenac
signiﬁcantly enhances the F1489Q mutant current measured in
the ND-96 solution, but has only a negligible effect on the current
measured in the ND-22 solution. The dotted line indicates the
zero current level. (B) The relative peak current in the ND-96 and
in the ND-22 solutions is determined by the same way as that
in Fig. 5 C. The dashed line indicates the relative peak current
of 1. Diclofenac enhancement of the F1489Q mutant current is
evidently weaker with the lower concentration of external Na .477 Yang and Kuo
that the major factor modulating the diclofenac effect
on Na  currents is the external rather than the internal
Na  ions. Fig. 10 B compares the effect of diclofenac on
the time to current peak in different internal and exter-
nal solutions. No matter the internal solution contains 0
or 150 mM Na , the time to peak current is always
lengthened by diclofenac if the external solution con-
tains 150 mM Na . On the other hand, when the exter-
nal solution contains no Na , the current peak is never
discernibly shifted by 10–3000  M of diclofenac in any
cell we examined (e.g., see the current traces in Fig. 8
B). It seems that high concentrations of diclofenac can
signiﬁcantly bind to the resting Na  channel and modify
subsequent gating (activation and inactivation) process
of the channel, reminiscent of signiﬁcant binding of
high concentrations of diclofenac onto the resting inac-
tivation-deﬁcient channel expressed in oocytes (with a
KR value of  880  M; Fig. 7). This gating effect of di-
clofenac is manifest in the presence of 150 mM external
Na  where diclofenac does not block the channel pore.
On the other hand, if binding of diclofenac to the rest-
ing channel blocks the channel pore (such as in the case
of 0 mM external Na ), the diclofenac-bound resting
channel could not conduct Na  ion even when it is sub-
sequently activated by a depolarization pulse, and thus
no apparent gating effect on the macroscopic activation
phase would be observed. These ﬁndings reinforce the
argument that only external Na , but not internal Na ,
effectively alters the blocking action of diclofenac. In
this case, the reduction of peak current in the absence
of external Na  would basically reﬂect the binding of di-
clofenac to the resting channel and serve as an estimate
Figure 10. Lack of signiﬁ-
cant effect of internal Na  on
diclofenac action and an esti-
mate of the binding afﬁnity
of diclofenac to the resting
neuronal Na  channel. (A)
Diclofenac action on macro-
scopic neuronal Na  currents
in the presence of symmetri-
cal 150 mM Na  (150 mM
Na  internal solution and
Tyrode’s solution containing
150 mM Na  extracellularly).
The neuron was held at
 120 mV and stepped to
 10 mV to elicit inward Na 
currents. The dotted line
indicates the zero current
level. The currents in the top
panel are rescaled to the
same peak level in the bottom
panel. 1 mM diclofenac
slightly but signiﬁcantly re-
duces  current peak and in-
creases the time to current
peak. However, it does not
accelerate the macroscopic
current decay. (B) Effect of
diclofenac on the time to
current peak in different
solutions. The current is
elicited by a test pulse of 0 or
 10 mV from a holding po-
tential of  120 mV in 150
mM external and 0 or 150 mM internal Na  (Ex150/In0 and Ex150/In150, respectively), or in 0 mM external and 150 mM internal Na 
(Ex0/In150). The test pulse is given beside each bar. In Ex150/In150 solution, the current cannot be measured at 0 mV and thus only that
measured at  10 mV is shown. The time to peak in the presence of 1 mM diclofenac is normalized to the time to peak in control to give
the relative time to peak. The dashed line indicates the relative time to peak of 1. When the external solution contains 150 mM external
Na , 1 mM diclofenac always increases the time to peak whether the internal solution contains 0 or 150 mM Na . In contrast, the time to
peak is always unchanged by 1 mM diclofenac if the external solution contains no Na  (0 mM external Na ). (C) Estimation of the
binding afﬁnity of diclofenac to the resting Na  channel in the absence of external Na . The neuronal Na  current is evoked by a pulse to
0 mV from a holding potential of  120 mV in 0 mM external and 150 mM internal Na . The peak current in the presence of diclofenac is
subtracted from the peak current in control and then normalized to the control current to give the relative reduction of peak current,
which is plotted against the diclofenac concentration. The line is a ﬁt to the data of the form: relative reduction of peak current  
(D/1483)/[1   (D/1483)], where D denotes the concentration of diclofenac in  M.478 An Opportunistic Blocker of the Na  Channel Pore
of the binding afﬁnity between diclofenac and the rest-
ing channel in this experimental condition. Fig. 10 C
plots the reduction of current peak against different
concentrations of diclofenac in the “0 mM Na ” exter-
nal solution. It is clear that the effect is far from satura-
tion even with 1 mM of diclofenac, and a rough estimate
of the dissociation constant of diclofenac binding to the
resting channel (KR) in the absence of external Na  is
 1500  M. The KR of diclofenac thus is probably not
very different in 96 mM external Na  ( 880  M; Fig. 7
D) or in the absence of external Na  ( 1500  M; Fig.
10 C), and is approximately in the low millimolar range
in both cases. External Na  thus may only slightly alter
the binding geometry and binding afﬁnity of diclofenac
onto the Na  channel, but the slight alteration could al-
ready result in very different functional consequences in
ion conduction through the pore.
DISCUSSION
The Location of the Diclofenac Binding Site in the 
Na  Channel
We have demonstrated that diclofenac selectively binds
to the activated and inactivated rather than the resting
Na  channel (Figs. 2 and 6), very much analogous to
the action of anticonvulsants carbamazepine, pheny-
toin, and lamotrigine (Kuo and Bean, 1994; Kuo and
Lu, 1997; Kuo et al., 1997). Diclofenac thus is also a
use-dependent inhibitor with one-to-one binding stoi-
chiometry (Fig. 8 C) to the Na  channel. However, di-
clofenac does not completely mimic the action of car-
bamazepine to block the open Na  channel pore (Yang
and Kuo, 2002). Diclofenac cannot block the pore in
the presence of 150 mM external Na  (Figs. 4–7), but is
turned into an effective pore blocker with decreased
external Na  concentration (Figs. 8 and 10). We fur-
ther show that the “opportunistic” pore-blocking effect
of diclofenac is chieﬂy modulated by external Na , but
has little to do with internal Na  or the direction of
current ﬂow (Figs. 8–10). Given its capability of block-
ing the pore at least in some experimental conditions,
diclofenac should have its binding site in the ion con-
duction pathway of the Na  channel. The ﬁndings
that only external but not internal Na  has an modula-
tory effect on the binding conformation of diclofenac
would further limit the diclofenac binding site to a
pore region that is effectively occupied by only external
but not internal Na  (see below). The diclofenac bind-
Figure 11. A schematic model de-
scribing one of the possible reasons why
carbamazepine and diclofenac may
bind to the same receptor area in the
external pore mouth of the Na 
channel  but produce different pore-
blocking effects in the presence or
absence of 150 mM external Na . The
diphenyl group in each drug is shown
by two black squares, which in general
have similar spatial orientation in these
two drugs. However, the two phenyl
groups are rigidly tied in carbamazepine
but are more ﬂexible (e.g., with more
versatile torsion angles) in diclofenac
(Table I). The shaded areas in the
channel  protein mark the location of
the binding ligands for the diphenyl
group. In the absence of external Na ,
the two drugs both bind to the gray
shaded areas in the external pore
mouth to compromise the narrow part
of the ion conduction pathway and
block ion ﬂow (left, 0 external Na ).
When Na  occupies the modulatory
Na  binding site in the external vesti-
bule in 150 mM external Na , local conformational changes happen with movement or reorientation of some potential binding ligands
for the diphenyl group (right). A wider shaded area suitable for binding of the diphenyl group is thus formed in the external vestibule
slightly farther away from the narrow part of the pore. With its more ﬂexible diphenyl group, diclofenac can readily bind to this wider
shaded area. The narrow part of the pore in the diclofenac-bound channel thus remains “patent” and permeable to Na . In contrast,
carbamazepine cannot effectively bind to the newly formed alternative receptive area because of its rigidly tied diphenyl group in the
dibenzazepine tricyclic structure. Carbamazepine would therefore bind to the same area as that in the absence of Na  and still blocks the
pore. The modulatory Na  binding site is probably located in the widened part of the external vestibule or even the external surface of
the channel, so that its occupancy is correlated with only external but not internal Na . On the other hand, the diclofenac binding site
should be located at the junction of the narrow and widened parts of the external pore mouth (presumably the junction of the external ves-
tibule and the single-ﬁle region of the pore), so that diclofenac could behave as an opportunistic pore blocker modulated by external Na .479 Yang and Kuo
ing site thus must be located very “superﬁcially” in the
pore (i.e., at the external pore mouth). In the mean-
while, the opportunistic blocking effect would require
diclofenac to bind to a site at the junction of a widened
and a narrow part of the ion conduction pathway, so
that its pore-blocking effect can be readily and drasti-
cally altered by some, presumably mild or modest, local
conformational changes induced by Na  binding (Fig.
11). Altogether these ﬁndings strongly indicate that di-
clofenac, a use-dependent inhibitor of the Na  chan-
nel, binds to a site at the junction of the widened exter-
nal vestibule and the narrow (possibly the selectivity ﬁl-
ter, see below) part of the pore.
A Low Afﬁnity Na  Binding Site in the External Vestibule 
of the Na  Channel Pore
The ﬁnding that diclofenac is an opportunistic pore
blocker modulated by external but not internal Na  is
reminiscent of, but far more characteristic than, the ob-
servations that the kinetics and efﬁcacy of many Na 
channel blockers might be inﬂuenced by external Na 
(Shapiro, 1977; Cahalan and Almers, 1979; O’Leary
and Chahine, 2002). In Shaker K  channels, the con-
formational change of the external vestibule near the
selectivity ﬁlter during C-type inactivation is also found
to be K  dependent (Ikeda and Korn, 1995; Baukrowitz
and Yellen, 1996; Immke et al., 1999). It is thus plausi-
ble that the permeating ions could modulate local con-
formation at the external pore mouth of an ion chan-
nel. There is a multi-ion single-ﬁle region at the exter-
nal pore mouth of the Na  channel, and this “narrow”
single-ﬁle pore region presumably is connected to the
external bulk solution by a wide vestibule (Ravindran et
al., 1991; Heinemann et al., 1992; Teresa Perez-Garcia
et al., 1997; Kuo et al., 2002). Moreover, external La3 
or other multivalent blocking ions binding to this sin-
gle-ﬁle pore region may profoundly retard Na  chan-
nel inactivation, indicating imperative gating confor-
mational changes in this external pore mouth area
(Kuo et al., 2004). Consistent with these views, our ﬁnd-
ings indicate that the gating-modifying (and gating-
modiﬁed) diclofenac receptor is located at the junction
of the narrow part of the ion conduction pathway and
the widened vestibule in the external pore mouth. The
experimental data further suggest that there is a Na 
site in the external vestibule of the pore, and Na  bind-
ing to this site would effectively modulate the binding
conformation of diclofenac (Fig. 11). Although this
Na -binding site is not too far away from the single-ﬁle
pore region, it is already in the widened vestibule and
thus can be effectively occupied by only external Na 
rather than internal Na  (which readily dissipates into
the external milieu when permeating to this point).
The afﬁnity of Na  to this ion binding site probably is
not high, considering that the effect of 22 mM external
Na  is still evidently different from 150 mM external
Na  (Fig. 9). However, it remains an interesting possi-
bility that Na  binding to this site may play a role in the
molecular operation of the Na  channel in physiologi-
cal conditions, which usually dictate  150 mM Na  in
the extracellular ﬂuid in mammals.
Continual Conformational Changes in the External Pore 
Mouth during Na  Channel Activation and Inactivation
Diclofenac binds to the inactivated Na  channel with a
much higher afﬁnity (KI of  7  M; Fig. 2) than to the
resting Na  channel (KR of  880 and  1500  M in the
presence and absence of external Na , respectively;
Fig. 7 D and Fig. 10 C). With the “patent” ion conduc-
tion pathway in the diclofenac-bound Na  channel in
150 mM external Na , we were able to show that di-
clofenac binds to and stabilizes the open Na  channel
with an intermediate afﬁnity (KO of  88  M; Fig. 6).
The effect of diclofenac on Na  channels itself proba-
bly has no clinical signiﬁcance, because the therapeutic
concentration of diclofenac is too low (Willis et al.,
1979) to make signiﬁcant binding to the Na  channel.
However, quantitative characterization of the binding
afﬁnity of a use-dependent inhibitor to all three major
gating states of the Na  channel is unprecedented, and
provides novel insight into the drug-channel interac-
tion. These experimental data indicate that the bind-
ing afﬁnity of diclofenac to the activated channel is
 10-fold ( 880  M vs.  88  M) higher than its bind-
ing to the resting channel, and is  13-fold ( 88  M
vs.  7  M) lower than its binding to the inactivated
channel. In other words, there are probably conforma-
tional changes in the drug receptor during activation
and subsequent inactivation gating process, causing
roughly  2.3RT ( 1.3 kcal/mol) and  2.6RT ( 1.5
kcal/mol) changes in the total binding energy of di-
clofenac, respectively. The continually altered binding
afﬁnity of diclofenac to the Na  channel during activa-
tion and inactivation implies continual conformational
changes in the diclofenac receptor, which may become
“better and better” for the binding of diclofenac along
the gating process triggered by membrane depolariza-
tion. Because diclofenac has only two benzene rings
but not a tertiary amine side chain (like that in local an-
esthetics) in structure, the ﬁndings in this study are
also consistent with the view that the binding counter-
part of the diphenyl motif in imipramine must undergo
signiﬁcant conformational changes in the gating pro-
cess of Na  channels (Yang and Kuo, 2002). In this re-
gard, it is worthy to note that the fourth transmem-
brane segment (S4), presumably the major voltage sen-
sor of the voltage-gated Na , K , and Ca2  channels, is
moved in close apposition to the extracellular end of
the pore upon membrane depolarization (Elinder et
al., 2001; Broomand et al., 2003; Gandhi et al., 2003).480 An Opportunistic Blocker of the Na  Channel Pore
Moreover, the extent and kinetics of Na  channel inac-
tivation are tightly and delicately controlled by the
movement of S4 in the fourth domain of the channel
protein (Yang and Kuo, 2003). It seems plausible that
the conformational changes in the diclofenac binding
site at the external pore mouth are actually coupled to,
or even caused by, the movement of S4, and thus the
use-dependent inhibitor of the Na  channel may have
its binding afﬁnity and binding kinetics well correlated
with the gating status of the channel.
Mutual Exclusion of Diclofenac and Carbamazepine Binding 
to the Na  Channel
There are two possible mechanisms underlying the
strict mutual exclusion of diclofenac and carbamaz-
epine binding to the Na  channel (Fig. 3). The two
drugs may share the same binding site, or they may
have different binding sites but the conformations fa-
vorable for drug binding in these two sites are allosteri-
cally and strictly incompatible with each other. The dif-
ferent effects of diclofenac and carbamazepine on ion
permeation (in 150 mM external Na ) seem to suggest
different drug binding sites. However, this is not neces-
sarily the case if one considers the more rigid torsion
angles of the diphenyl motif in carbamazepine and
consequently a more versatile binding conformation of
diclofenac than carbamazepine (Fig. 11). On the other
hand, the two drugs have similar structure and similar
gating modiﬁcation as well as pore-blocking effects (in
0 mM external Na ) on the Na  channel. They also
show similar changes in binding kinetics upon the acti-
vation–inactivation transition of the channel. These
ﬁndings can be straightforward envisioned with a com-
mon binding site for diclofenac and carbamazepine.
Although the possibility of two different sites cannot be
completely excluded with these ﬁndings, the two sites
must be both in the pore, and both undergo very simi-
lar conformational changes along channel activation
and inactivation. Also, the conformations favorable for
drug binding in each site must be allosterically and
strictly incompatible with each other. If future data do
support two separate sites for carbamazepine and di-
clofenac, then one should be aware of the existence of
multiple mutually incompatible binding sites for the
use-dependent inhibitors of the Na  channel. On the
other hand, if the two drugs indeed bind to the same
site, then we may locate the common anticonvulsant re-
ceptor at the junction of the widened external vestibule
and an acutely narrowed part of the Na  channel pore,
given the characteristic external Na -modulated “op-
portunistic” pore-blocking effect of diclofenac.
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